Beta-alanyl-3-methyl-L-histidine prevents tau-mediated neurodegeneration and cognitive decline by inhibiting astrocytes activation via NF-kB signaling pathway

○CHENXU LEI

Presentation information

Oral

H. Disorders of Nervous Systems

[2O07m-2] Dementia 2

Wed. Aug 2, 2023 9:45 AM - 10:45 AM Room 7 (Shirakashi 2)

Chair: Taisuke Tomita (Graduate School of Pharmaceutical Sciences, The University of Tokyo), Makoto Higuchi (National Institutes for Quantum Science and Technology)

[2O07m-2-02] Beta-alanyl-3-methyl-L-histidine prevents tau-mediated neurodegeneration and cognitive decline by inhibiting astrocytes activation via NF-kB signaling pathway

○CHENXU LEI¹, Tatsuhiro Hisatsune¹ (1. Graduate School of Frontier Sciences, The University of Tokyo)

Keywords:Alzheimer's disease, Tau pathology, Neuroinflammation, Anserine

Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.

https://membership.jnss.org/C00/login

Presentation information

[2O07m-2] Dementia 2

[2O07m-2-02] Beta-alanyl-3-methyl-L-histidine prevents tau-mediated neurodegeneration and cognitive decline by inhibiting astrocytes activation via NF-kB signaling pathway

Password